Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of Sequella, Inc. patents

List of Sequella, Inc. patents

List of Pensando Systems patents

List of Avon Protection Systems patents

List of Seaquist Closures patents

Strategic partnerships in banking

List of companies in CrestValue's investment portfolio

Patents where

Current Assignee

Name

is

‌

Sequella, Inc.

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 7884097 Methods and compositions comprising diamines as new anti-tubercular therapeutics	Patent 7884097 was granted and assigned to Sequella, Inc. on February, 2011 by the United States Patent and Trademark Office.		‌ Sequella, Inc.		United States Patent and Trademark Office	7884097	February 8, 2011
	‌ US Patent 8202910 Compositions and methods for treatment of infectious disease	Patent 8202910 was granted and assigned to Sequella, Inc. on June, 2012 by the United States Patent and Trademark Office.		‌ Sequella, Inc.		United States Patent and Trademark Office	8202910	June 19, 2012
	‌ US Patent 7652039 Methods of use and compositions for the diagnosis and treatment of infectious disease	Patent 7652039 was granted and assigned to Sequella, Inc. on January, 2010 by the United States Patent and Trademark Office.		‌ Sequella, Inc.		United States Patent and Trademark Office	7652039	January 26, 2010
	‌ US Patent 8198303 Methods of use and compositions for the diagnosis and treatment of infectious diseases	Patent 8198303 was granted and assigned to Sequella, Inc. on June, 2012 by the United States Patent and Trademark Office.		‌ Sequella, Inc.		United States Patent and Trademark Office	8198303	June 12, 2012
	‌ US Patent 7919234 Methods and compositions for determining the pathogenic status of infectious agents	Patent 7919234 was granted and assigned to Sequella, Inc. on April, 2011 by the United States Patent and Trademark Office.		‌ Sequella, Inc.		United States Patent and Trademark Office	7919234	April 5, 2011
	‌ US Patent 8501400 Methods and compositions for determining the pathogenic status of infectious agents			‌ Sequella, Inc.		United States Patent and Trademark Office	8501400	August 6, 2013

6 results

0 selected

6 results

0 selected